{
    "clinical_study": {
        "@rank": "119404", 
        "arm_group": {
            "arm_group_label": "children with Type 1 diabetes", 
            "description": "Each subject will wear enlite and enlite 2 sensors"
        }, 
        "biospec_descr": {
            "textblock": "Blood"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the Enlite Sensor\u2122 and Enlite 2 Sensor performance\n      in pediatric patients with insulin requiring diabetes at the beginning, middle and end of\n      sensor wear."
        }, 
        "brief_title": "CEP249 Pediatric Accuracy Study", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a prospective, single arm, multi-center, in-clinic study with one treatment\n      group assignment.  There will be two consecutive phases of the study:\n\n      A total of up to 150 subjects will be enrolled at up to 11 investigational centers\n\n      Subjects will come for clinic visit for YSI testing\n\n      Study has three periods and 9 visits"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is 2-18 years of age at time of screening\n\n          2. Subject has been diagnosed with insulin requiring diabetes mellitus for at least one\n             year.\n\n          3. Subject is willing to perform greater than or equal to 4 finger stick blood glucose\n             measurements daily\n\n          4. Subject is willing to perform required sensor calibrations\n\n          5. Subject is willing to wear the system (pumps, sensors, meter) continuously throughout\n             the study\n\n             Additional Inclusion Criteria that are based on Demands of In-Clinic Study Procedures\n\n          6. Adequate venous access as assessed by investigator or appropriate staff\n\n        Exclusion Criteria:\n\n          1. Subject is unable to tolerate tape adhesive in the area of sensor placement\n\n          2. Subject has any unresolved adverse skin condition in the area of sensor or device\n             placement (e.g., psoriasis, rash, Staphylococcus infection)\n\n          3. Subject is actively participating in an investigational study (drug or device)\n             wherein they have received treatment from an investigational study (drug or device)\n             in the last 2 weeks\n\n          4. Females of child-bearing potential who have a positive pregnancy test at screening or\n             plans to become pregnant during the course of the study\n\n          5. Subjects with hematocrit lower than the normal age specific reference range per\n             central or local lab testing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "2 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Children from 2-18 years of age"
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01991470", 
            "org_study_id": "CEP249"
        }, 
        "intervention": {
            "arm_group_label": "children with Type 1 diabetes", 
            "description": "Subject wears both enlite and enlite 2 sensors", 
            "intervention_name": "Sensor", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Type 1 diabetes", 
            "Children", 
            "Sensor", 
            "Accuracy"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": {
            "contact": {
                "last_name": "Kristen Hughes", 
                "phone": "425-251-1720", 
                "phone_ext": "15"
            }, 
            "facility": {
                "address": {
                    "city": "Renton", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98057"
                }, 
                "name": "Rainier Clinical Research Center"
            }, 
            "investigator": {
                "last_name": "Ronald Brazg, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Performance Evaluation of the Enlite\u2122 and Enlite 2 Glucose Sensor to Support a Full 144 Hours (6 Days) of Use in Children", 
        "overall_contact": {
            "email": "yiming.deng@medtronic.com", 
            "last_name": "Yiming Deng, TCL", 
            "phone": "818-756-5472"
        }, 
        "overall_contact_backup": {
            "email": "bob.janowski@medtronic.com", 
            "last_name": "Bob Janowski, Manager", 
            "phone": "818-756-5662"
        }, 
        "overall_official": {
            "affiliation": "Rainier Clinical Research Center", 
            "last_name": "Ronald Brazg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Glucose sensor values will be compared to Yellow Spring Instruments (YSI) plasma glucose values during Frequent Sample Testing.", 
            "measure": "Sensor accuracy with minimum calibrations", 
            "safety_issue": "Yes", 
            "time_frame": "6 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01991470"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtronic Diabetes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Diabetes", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}